The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARα.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 04 2019
Historique:
received: 27 05 2018
accepted: 20 03 2019
entrez: 7 4 2019
pubmed: 7 4 2019
medline: 10 5 2019
Statut: epublish

Résumé

The class 3 phosphoinositide 3-kinase (PI3K) is required for lysosomal degradation by autophagy and vesicular trafficking, assuring nutrient availability. Mitochondrial lipid catabolism is another energy source. Autophagy and mitochondrial metabolism are transcriptionally controlled by nutrient sensing nuclear receptors. However, the class 3 PI3K contribution to this regulation is unknown. We show that liver-specific inactivation of Vps15, the essential regulatory subunit of the class 3 PI3K, elicits mitochondrial depletion and failure to oxidize fatty acids. Mechanistically, transcriptional activity of Peroxisome Proliferator Activated Receptor alpha (PPARα), a nuclear receptor orchestrating lipid catabolism, is blunted in Vps15-deficient livers. We find PPARα repressors Histone Deacetylase 3 (Hdac3) and Nuclear receptor co-repressor 1 (NCoR1) accumulated in Vps15-deficient livers due to defective autophagy. Activation of PPARα or inhibition of Hdac3 restored mitochondrial biogenesis and lipid oxidation in Vps15-deficient hepatocytes. These findings reveal roles for the class 3 PI3K and autophagy in transcriptional coordination of mitochondrial metabolism.

Identifiants

pubmed: 30952952
doi: 10.1038/s41467-019-09598-9
pii: 10.1038/s41467-019-09598-9
pmc: PMC6451001
doi:

Substances chimiques

Ncor1 protein, mouse 0
Nuclear Receptor Co-Repressor 1 0
PPAR alpha 0
Phosphatidylinositol 3-Kinases EC 2.7.1.-
Vacuolar Sorting Protein VPS15 EC 2.7.11.1
Histone Deacetylases EC 3.5.1.98
histone deacetylase 3 EC 3.5.1.98
Fenofibrate U202363UOS

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1566

Références

Nat Commun. 2012 Feb 14;3:672
pubmed: 22334075
Autophagy. 2007 Jul-Aug;3(4):337-46
pubmed: 17404498
J Biol Chem. 2007 Aug 17;282(33):24131-45
pubmed: 17580304
Methods Enzymol. 2015;561:171-96
pubmed: 26358905
Diabetes. 2005 Aug;54(8):2460-70
pubmed: 16046315
Nat Cell Biol. 2009 Apr;11(4):468-76
pubmed: 19270693
Nat Protoc. 2007;2(2):287-95
pubmed: 17406588
Cell Metab. 2005 May;1(5):309-22
pubmed: 16054078
Cell Metab. 2005 Feb;1(2):133-44
pubmed: 16054054
Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2003-8
pubmed: 22308354
Nat Chem Biol. 2010 Jul;6(7):507-13
pubmed: 20559318
J Biol Chem. 2010 Dec 24;285(52):40409-15
pubmed: 20956526
Science. 2009 Jul 24;325(5939):473-7
pubmed: 19556463
J Cell Biol. 2005 May 9;169(3):425-34
pubmed: 15866887
Cell Metab. 2009 Dec;10(6):507-15
pubmed: 19945408
Nat Rev Mol Cell Biol. 2011 Jan;12(1):9-14
pubmed: 21179058
Nature. 2001 Dec 13;414(6865):799-806
pubmed: 11742412
Autophagy. 2011 Jul;7(7):727-36
pubmed: 21471734
Genes Dev. 2013 Apr 15;27(8):819-35
pubmed: 23630073
Cell. 2010 May 14;141(4):656-67
pubmed: 20478256
Nature. 2004 Dec 23;432(7020):1032-6
pubmed: 15525940
J Cell Biol. 2017 Mar 6;216(3):675-693
pubmed: 28188211
Nature. 2010 Dec 23;468(7327):1100-4
pubmed: 21179166
Blood. 2008 Aug 15;112(4):1493-502
pubmed: 18539900
Hepatology. 2015 Nov;62(5):1606-18
pubmed: 25998209
Autophagy. 2013 Jul;9(7):1097-9
pubmed: 23614954
Nat Cell Biol. 2013 Jun;15(6):647-58
pubmed: 23604321
EMBO Mol Med. 2013 Jun;5(6):870-90
pubmed: 23630012
EMBO J. 2012 Mar 7;31(5):1095-108
pubmed: 22343943
Nature. 2014 Dec 4;516(7529):112-5
pubmed: 25383539
PLoS One. 2013 Oct 03;8(10):e76405
pubmed: 24098492
Nat Med. 2004 May;10(5):530-4
pubmed: 15107844
J Biol Chem. 2012 Nov 16;287(47):39275-90
pubmed: 23043107
J Clin Invest. 2013 Jun;123(6):2564-75
pubmed: 23676496
J Biol Chem. 1997 Jan 24;272(4):2477-85
pubmed: 8999962
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4318-23
pubmed: 9113987
Hum Mol Genet. 2011 Oct 1;20(19):3852-66
pubmed: 21752829
Nature. 2014 Dec 4;516(7529):108-11
pubmed: 25383523
Biochem J. 2016 Aug 1;473(15):2251-71
pubmed: 27470591
Nat Commun. 2017 Nov 27;8(1):1804
pubmed: 29180704
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7473-8
pubmed: 10377439
Sci Rep. 2016 Jan 06;6:18944
pubmed: 26732653
Nature. 2013 Jan 31;493(7434):679-83
pubmed: 23263183
Mol Cell Biol. 2000 Mar;20(5):1868-76
pubmed: 10669761
Nature. 2010 Mar 11;464(7286):243-9
pubmed: 20190736
J Clin Invest. 1999 Jun;103(11):1489-98
pubmed: 10359558
Clin Chim Acta. 2006 Dec;374(1-2):81-6
pubmed: 16828729
J Cell Biol. 2008 Dec 1;183(5):795-803
pubmed: 19029340
Trends Endocrinol Metab. 2012 Sep;23(9):459-66
pubmed: 22817841
Nat Commun. 2015 Sep 21;6:8283
pubmed: 26387534
Dev Cell. 2015 Mar 23;32(6):678-92
pubmed: 25752962
PLoS One. 2011 Jan 20;6(1):e16358
pubmed: 21283715
EMBO J. 2001 Dec 17;20(24):6969-78
pubmed: 11742974
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312-7
pubmed: 9113986
Nat Med. 2013 Jan;19(1):83-92
pubmed: 23202295
J Clin Invest. 2017 May 1;127(5):1873-1888
pubmed: 28394260
Cell Death Differ. 2015 Mar;22(3):499-508
pubmed: 25571976
Cell Rep. 2018 Aug 28;24(9):2404-2417.e8
pubmed: 30157433
Mol Endocrinol. 2013 Oct;27(10):1643-54
pubmed: 23960084
Biochem Biophys Res Commun. 2001 Oct 19;288(1):106-10
pubmed: 11594759
Hepatology. 2018 Jul;68(1):289-303
pubmed: 29331071
Science. 2011 Jun 17;332(6036):1429-33
pubmed: 21617040
J Biol Chem. 2002 Oct 4;277(40):37254-9
pubmed: 12118000
Gut. 2016 Jul;65(7):1202-14
pubmed: 26838599
Nat Cell Biol. 2009 Apr;11(4):385-96
pubmed: 19270696
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9424-9
pubmed: 20439739
Cell Metab. 2011 Nov 2;14(5):598-611
pubmed: 22055503

Auteurs

Anton Iershov (A)

Institut Necker-Enfants Malades (INEM), 75014, Paris, France.
INSERM U1151/CNRS UMR 8253, 75014, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, 75006, Paris, France.

Ivan Nemazanyy (I)

Institut Necker-Enfants Malades (INEM), 75014, Paris, France.
INSERM U1151/CNRS UMR 8253, 75014, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, 75006, Paris, France.
Platform for Metabolic Analyses, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS 3633, 75014, Paris, France.

Chantal Alkhoury (C)

Institut Necker-Enfants Malades (INEM), 75014, Paris, France.
INSERM U1151/CNRS UMR 8253, 75014, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, 75006, Paris, France.

Muriel Girard (M)

Institut Necker-Enfants Malades (INEM), 75014, Paris, France.
INSERM U1151/CNRS UMR 8253, 75014, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, 75006, Paris, France.
Pediatric Hepatology Unit, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France.

Esther Barth (E)

Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50674, Cologne, Germany.

Nicolas Cagnard (N)

Plateforme Bio-informatique, Université Paris Descartes, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS 3633, Paris, 75015, France.

Alexandra Montagner (A)

INSERM U1048, Université Paul Sabatier, Toulouse, 31432, France.

Dominique Chretien (D)

INSERM UMR1141, Hôpital Robert Debré, Paris, 75019, France.
Université Paris 7, Faculté de Médecine Denis Diderot, Paris, 75019, France.

Elena I Rugarli (EI)

Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50674, Cologne, Germany.

Herve Guillou (H)

Toxalim, Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, 31027, France.

Mario Pende (M)

Institut Necker-Enfants Malades (INEM), 75014, Paris, France.
INSERM U1151/CNRS UMR 8253, 75014, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, 75006, Paris, France.

Ganna Panasyuk (G)

Institut Necker-Enfants Malades (INEM), 75014, Paris, France. ganna.panasyuk@inserm.fr.
INSERM U1151/CNRS UMR 8253, 75014, Paris, France. ganna.panasyuk@inserm.fr.
Université Paris Descartes, Sorbonne Paris Cité, 75006, Paris, France. ganna.panasyuk@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH